東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Acute kidney injury and regenerative...

Terada, Yoshio.

Linked to FindBook

Google Book

Amazon

博客來

Acute kidney injury and regenerative medicine

Record Type:	Electronic resources : Monograph/item
Title/Author:	Acute kidney injury and regenerative medicine/ edited by Yoshio Terada, Takashi Wada, Kent Doi.
other author:	Terada, Yoshio.
Published:	Singapore :Springer Singapore : : 2020.,
Description:	ix, 396 p. :ill., digital ;24 cm.
[NT 15003449]:	Part 1 Diagnosis and risk factors of AKI -- Definition and epidemiology of AKI -- Cause of AKI (prerenal, renal, postrenal) -- Pathophysiology of AKI -- Diagnosis of AKI (clinical assessment, novel biomarkers) -- Risk factors for AKI development in surgery -- Risk factors for AKI development in heart failure -- 7. Contrast-induced AKI -- 8. Antibiotics- and immunosuppression-related AKI -- 9. AKI in setting of cancer -- Community-acquired AKI and hospital-acquired AKI -- Part 2 Complication of AKI -- 11. Complication of homeostasis (mineral and acid-base) -- 12. Volume overload and cardiac and pulmonary complication -- Part 3 Prevention and management of AKI -- Prerenal and renal AKI -- Postrenal AKI -- AKI in intensive care medicine -- Nondialytic supportive management of AKI -- Renal replacement therapy in AKI -- Outcomes and long-term follow-up of AKI patients -- Prevention and management of pediatric AKI -- Part 4 Experimental novel findings -- AKI-to-CKD transition -- AKI and nerve system -- AKI and immune system -- AKI and cytokines -- Part 5 AKI and regenerative medicine -- iPS cell and renal regenerative medicine -- Embryonic genes and renal regenerative medicine -- Xenotransplanted embryonic kidney.
Contained By:	Springer eBooks
Subject:	Kidneys - Wounds and injuries. -
Online resource:	https://doi.org/10.1007/978-981-15-1108-0
ISBN:	9789811511080

Acute kidney injury and regenerative medicine
Acute kidney injury and regenerative medicine[electronic resource] /edited by Yoshio Terada, Takashi Wada, Kent Doi. - Singapore :Springer Singapore :2020. - ix, 396 p. :ill., digital ;24 cm.

Part 1 Diagnosis and risk factors of AKI -- Definition and epidemiology of AKI -- Cause of AKI (prerenal, renal, postrenal) -- Pathophysiology of AKI -- Diagnosis of AKI (clinical assessment, novel biomarkers) -- Risk factors for AKI development in surgery -- Risk factors for AKI development in heart failure -- 7. Contrast-induced AKI -- 8. Antibiotics- and immunosuppression-related AKI -- 9. AKI in setting of cancer -- Community-acquired AKI and hospital-acquired AKI -- Part 2 Complication of AKI -- 11. Complication of homeostasis (mineral and acid-base) -- 12. Volume overload and cardiac and pulmonary complication -- Part 3 Prevention and management of AKI -- Prerenal and renal AKI -- Postrenal AKI -- AKI in intensive care medicine -- Nondialytic supportive management of AKI -- Renal replacement therapy in AKI -- Outcomes and long-term follow-up of AKI patients -- Prevention and management of pediatric AKI -- Part 4 Experimental novel findings -- AKI-to-CKD transition -- AKI and nerve system -- AKI and immune system -- AKI and cytokines -- Part 5 AKI and regenerative medicine -- iPS cell and renal regenerative medicine -- Embryonic genes and renal regenerative medicine -- Xenotransplanted embryonic kidney.

This book presents up-to-date information on the clinical-pathophysiological features of acute renal injury and discusses the KDIGO diagnostic criteria, as well as novel experimental findings, including in the area of regenerative medicine. It also highlights the clinical-pathophysiological importance of AKI in clinical settings, including differential diagnoses and management of AKI. In the past, the pathology associated with sudden renal impairment was characterized as acute renal failure (ARF) However, in the 2000s, the joint efforts of specialists in fields including nephrology, intensive care medicine, and cardiovascular medicine led to the introduction of a novel concept known as acute kidney injury (AKI) As medical care progressed, patients such as high-risk elderly subjects who were not deemed to be candidates for invasive therapy came to be treated in intensive care units (ICUs) As a result, kidney injury as a subset of multiple organ failure was re-considered as AKI, especially in intensive care medicine. AKI was then proposed as a novel disease concept to emphasize the importance of early diagnosis and early intervention to improve prognosis. Presenting novel features, such as the definition of AKI, risk factors and management; biomarkers, such as neutrophil gelatinase-associated lipocalin (NGAL) and L-type fatty acid-binding protein (L-FABP); long-term outcomes of AKI; as well as renal regeneration using iPS cell, manipulation of embryonic genes, and Xenotransplanted embryonic kidney, this book is of interest to all physicians and researchers in this field around the globe.

ISBN: 9789811511080

Standard No.: 10.1007/978-981-15-1108-0doiSubjects--Topical Terms:

1574356
Kidneys
--Wounds and injuries.

LC Class. No.: RC918.R4 / A288 2020

Dewey Class. No.: 616.61

Acute kidney injury and regenerative medicine
LDR:03818nmm a2200325 a 4500 001 2255377
003 DE-He213
005 20200514130104.0
006 m d
007 cr nn 008maaau
008 220419s2020 si s 0 eng d
020 $a 9789811511080 $q (electronic bk.)
020 $a 9789811511073 $q (paper)
024 7 $a 10.1007/978-981-15-1108-0 $2 doi
035 $a 978-981-15-1108-0
040 $a GP $c GP
041 0 $a eng
050 4 $a RC918.R4 $b A288 2020
072 7 $a MJR $2 bicssc
072 7 $a MED055000 $2 bisacsh
072 7 $a MJR $2 thema
082 0 4 $a 616.61 $2 23
090 $a RC918.R4 $b A189 2020
245 0 0 $a Acute kidney injury and regenerative medicine $h [electronic resource] / $c edited by Yoshio Terada, Takashi Wada, Kent Doi.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2020.
300 $a ix, 396 p. : $b ill., digital ; $c 24 cm.
505 0 $a Part 1 Diagnosis and risk factors of AKI -- Definition and epidemiology of AKI -- Cause of AKI (prerenal, renal, postrenal) -- Pathophysiology of AKI -- Diagnosis of AKI (clinical assessment, novel biomarkers) -- Risk factors for AKI development in surgery -- Risk factors for AKI development in heart failure -- 7. Contrast-induced AKI -- 8. Antibiotics- and immunosuppression-related AKI -- 9. AKI in setting of cancer -- Community-acquired AKI and hospital-acquired AKI -- Part 2 Complication of AKI -- 11. Complication of homeostasis (mineral and acid-base) -- 12. Volume overload and cardiac and pulmonary complication -- Part 3 Prevention and management of AKI -- Prerenal and renal AKI -- Postrenal AKI -- AKI in intensive care medicine -- Nondialytic supportive management of AKI -- Renal replacement therapy in AKI -- Outcomes and long-term follow-up of AKI patients -- Prevention and management of pediatric AKI -- Part 4 Experimental novel findings -- AKI-to-CKD transition -- AKI and nerve system -- AKI and immune system -- AKI and cytokines -- Part 5 AKI and regenerative medicine -- iPS cell and renal regenerative medicine -- Embryonic genes and renal regenerative medicine -- Xenotransplanted embryonic kidney.
520 $a This book presents up-to-date information on the clinical-pathophysiological features of acute renal injury and discusses the KDIGO diagnostic criteria, as well as novel experimental findings, including in the area of regenerative medicine. It also highlights the clinical-pathophysiological importance of AKI in clinical settings, including differential diagnoses and management of AKI. In the past, the pathology associated with sudden renal impairment was characterized as acute renal failure (ARF) However, in the 2000s, the joint efforts of specialists in fields including nephrology, intensive care medicine, and cardiovascular medicine led to the introduction of a novel concept known as acute kidney injury (AKI) As medical care progressed, patients such as high-risk elderly subjects who were not deemed to be candidates for invasive therapy came to be treated in intensive care units (ICUs) As a result, kidney injury as a subset of multiple organ failure was re-considered as AKI, especially in intensive care medicine. AKI was then proposed as a novel disease concept to emphasize the importance of early diagnosis and early intervention to improve prognosis. Presenting novel features, such as the definition of AKI, risk factors and management; biomarkers, such as neutrophil gelatinase-associated lipocalin (NGAL) and L-type fatty acid-binding protein (L-FABP); long-term outcomes of AKI; as well as renal regeneration using iPS cell, manipulation of embryonic genes, and Xenotransplanted embryonic kidney, this book is of interest to all physicians and researchers in this field around the globe.
650 0 $a Kidneys $x Wounds and injuries. $3 1574356
650 0 $a Regenerative medicine. $3 1002441
650 1 4 $a Nephrology. $3 894870
650 2 4 $a Regenerative Medicine/Tissue Engineering. $3 2055677
700 1 $a Terada, Yoshio. $3 3524909
700 1 $a Wada, Takashi. $3 3488955
700 1 $a Doi, Kent. $3 3524910
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u https://doi.org/10.1007/978-981-15-1108-0
950 $a Medicine (Springer-11650)